Dian Diagnostics Group Co (SZSE:300244) LT-Debt-to-Total-Asset : 0.14 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Dian Diagnostics Group Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.14.

Dian Diagnostics Group Co's long-term debt to total assets ratio declined from Mar. 2023 (0.15) to Mar. 2024 (0.14). It may suggest that Dian Diagnostics Group Co is progressively becoming less dependent on debt to grow their business.

Dian Diagnostics Group Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Dian Diagnostics Group Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co LT-Debt-to-Total-Asset Chart

Dian Diagnostics Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.10

0.07

0.08

0.16

0.15

Dian Diagnostics Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.15	0.15	0.14	0.15	0.14

Dian Diagnostics Group Co LT-Debt-to-Total-Asset Calculation

Dian Diagnostics Group Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	2619.611	/	17939.311
	=	0.15

Dian Diagnostics Group Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	2556.435	/	17855.213
	=	0.14

Dian Diagnostics Group Co (SZSE:300244) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Dian Diagnostics Group Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Dian Diagnostics Group Co (SZSE:300244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030

Website

http://www.dazd.cn

Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.

Executives

Chen Hai Bin	Director
Chen Shi Shi	Supervisors
Guo San Hui	Executives
Yao Shu Lie	Executives
Xu Min	Director
Wang Yan Xiao	Directors, executives
Chen Zuo Xiu	Directors, executives
Hu Yong	Director
Hu Miao Shen	Executives
Chen Xue Dong	Director
Jiang Tang	Directors, executives
Tao Jun	Securities Affairs Representative
Wu Zheng Xin	Executives
Cheng Xiu Li	Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines